Pharmacokinetic, Safety and Efficacy of Intermittent Application of Caspofungin for Antifungal Prophylaxis
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
The study is a pilot phase II, prospective, non-comparative, single center trial aimed to
evaluate pharmacokinetic and safety of an intermittent dosing schedule for antifungal
prophylaxis in high risk patients.